World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
70
Citations
17859
World Ranking
6995
National Ranking
125

Overview

Yves Beguin is affiliated with the University of Liège in Belgium and conducts research primarily in the field of medicine, with a significant focus on hematology. Their body of work spans subfields such as genetics, oncology, immunology, and infectious diseases.

Their research topics include:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • CAR-T cell therapy research
  • Acute Lymphoblastic Leukemia research
  • Chronic Lymphocytic Leukemia Research
  • SARS-CoV-2 and COVID-19 Research

Yves Beguin has published extensively in several key scientific journals. Frequent publication venues include:

  • Blood
  • Bone Marrow Transplantation
  • Frontiers in Immunology
  • Transplantation and Cellular Therapy
  • Bulletin du Cancer

Among recent papers authored by or co-authored with Yves Beguin are:

  • "Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3" (2024), Journal of Clinical Oncology
  • "Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies" (2020), Frontiers in Immunology
  • "Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT" (2021), Leukemia
  • "Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data" (2020), Pharmaceutics
  • "Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients" (2021), Journal of Hematology & Oncology

The scientist frequently collaborates with other researchers, including:

  • Frédéric Baron
  • Ibrahim Yakoub-Agha
  • Yves Chalandon
  • Sophie Servais
  • Marie Robin

Best Publications

  • Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.

    Guy Jerusalem;Yves Beguin;Marie-France Fassotte;F. Najjar

  • Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation.

    D. De Groote;P.F. Zangerle;Y. Gevaert;M.F. Fassotte

  • Soluble transferrin receptor for the evaluation of erythropoiesis and iron status.

    Yves Beguin

  • Intact transferrin receptors in human plasma and their relation to erythropoiesis.

    Helmut A. Huebers;Yves Beguin;Pensri Pootrakul;David Einspahr

  • Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium.

    Christiane Vermylen;Guy Cornu;A. Ferster;Bénédicte Brichard

  • Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin

    Yves Beguin;Gisela K. Clemons;Pensri Pootrakul;Georges Fillet

  • Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.

    Frédéric Baron;Chantal Lechanteur;Evelyne Willems

  • Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease

    Guy Jerusalem;Yves Beguin;Marie-France Fassotte;T. Belhocine

  • Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma.

    Guy Jerusalem;Yves Beguin;Marie-France Fassotte;Fadi Najjar

  • Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease

    Guy Jerusalem;Yves Beguin;Marie-France Fassotte;F. Najjar

  • Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines†

    Aapro M;Beguin Y;Bokemeyer C;Dicato M

  • Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies

    Gandhi Damaj;Alain Duhamel;Marie Robin;Yves Beguin

  • KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia.

    R. Willemze;R. Willemze;C. A. Rodrigues;M. Labopin;G. Sanz

  • Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group

    Diana Averbuch;Gloria Tridello;Jennifer Hoek;Malgorzata Mikulska

  • Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.

    M. Cazzola;L. Ponchio;F. de Benedetti;A. Ravelli

  • Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron

    Matti S. Aapro;Anders C. Osterborg;Pere Gascon;Heinrich P. Ludwig

  • Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation.

    Georges Fillet;Yves Beguin;Laurent Baldelli

  • Iron metabolism and erythropoiesis after surgery

    C. E. van Iperen;Rob J. Kraaijenhagen;D. H. Biesma;Yves Beguin

  • Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production.

    Mario Cazzola;Yves Beguin;Janusz Kloczko;Ivan Spicka

  • The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood.

    Mustapha Zeddou;Alexandra Briquet;Biserka Relic;Claire Josse

Frequent Co-Authors

Frédéric Baron
Frédéric Baron University of Liège
Mauricette Michallet
Mauricette Michallet University of Helsinki
Gérard Socié
Gérard Socié Université Paris Cité
Mario Cazzola
Mario Cazzola University of Pavia
Arnon Nagler
Arnon Nagler Sheba Medical Center
Philippe Delvenne
Philippe Delvenne University of Liège
Dominique Bron
Dominique Bron Université Libre de Bruxelles
Myriam Labopin
Myriam Labopin Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring an education in Biology or Biochemistry can open the door to many career opportunities—often beyond the laboratory. For students interested in healthcare, some choose to start with entry-level certifications and pursue advanced options as they progress.

Many students begin by looking for financial aid for medical assistant programs, an affordable and accessible stepping stone into healthcare roles. For those already working as medical assistants, flexible ma to lpn bridge programs online help advance your credentials and responsibilities without leaving your job.

Ambitious learners aiming for careers in research, biotech, or advanced healthcare may consider earning their degree online. Completing an online biology degree can provide a strong scientific foundation and the flexibility to balance work and study.

For those targeting a nursing pathway, an online asn program offers an efficient route toward becoming a registered nurse. Each pathway comes with unique requirements, timelines, and career outcomes—so research thoroughly to choose the right fit for your professional goals.

Best Scientists Citing Yves Beguin

Trending Scientists

Recently Published Articles